tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LYPHF Stock Latest News

Luye Pharma Initiates Phase II Trial for CNS Drug LY03015 in China
Company AnnouncementsLuye Pharma Initiates Phase II Trial for CNS Drug LY03015 in China
16d ago
Luye Pharma’s New Antipsychotic Drug LY03020 Approved for U.S. Clinical Trials
PremiumCompany Announcements
Luye Pharma’s New Antipsychotic Drug LY03020 Approved for U.S. Clinical Trials
17d ago
Luye Pharma Chairman Increases Stake, Signals Confidence
PremiumCompany Announcements
Luye Pharma Chairman Increases Stake, Signals Confidence
1M ago
Luye Pharma Announces Convertible Bond Issuance
PremiumCompany Announcements
Luye Pharma Announces Convertible Bond Issuance
2M ago
Luye Pharma Bolsters Liquidity with $50M Bond Issue
PremiumCompany Announcements
Luye Pharma Bolsters Liquidity with $50M Bond Issue
2M ago
Luye Pharma Gains Approval for Cancer Drug Zepzelca
PremiumCompany AnnouncementsLuye Pharma Gains Approval for Cancer Drug Zepzelca
2M ago
Luye Pharma Gains Ground with New Drug Inclusions
Premium
Company Announcements
Luye Pharma Gains Ground with New Drug Inclusions
2M ago
Luye Pharma Gains Approval for Innovative Antidepressant Trials
Premium
Company Announcements
Luye Pharma Gains Approval for Innovative Antidepressant Trials
3M ago
Luye Pharma’s $100 Million Convertible Bonds Issuance
PremiumCompany Announcements
Luye Pharma’s $100 Million Convertible Bonds Issuance
3M ago
Luye Pharma Boosts Liquidity with $100M Bond Issue
PremiumCompany Announcements
Luye Pharma Boosts Liquidity with $100M Bond Issue
3M ago
Luye Pharma Adjusts Closing Date for Bond Issue
PremiumCompany Announcements
Luye Pharma Adjusts Closing Date for Bond Issue
3M ago
Luye Pharma Group to Issue $150M Convertible Bonds
PremiumCompany Announcements
Luye Pharma Group to Issue $150M Convertible Bonds
3M ago
Luye Pharma Group Reports Strong Mid-Year Financials
PremiumCompany AnnouncementsLuye Pharma Group Reports Strong Mid-Year Financials
5M ago
Luye Pharma Sets Date for Financial Results Review
Premium
Company Announcements
Luye Pharma Sets Date for Financial Results Review
6M ago
Luye Pharma Group Completes Key Investment Phase
Premium
Company Announcements
Luye Pharma Group Completes Key Investment Phase
6M ago
Luye Pharma’s Breakthrough Drug Enters Clinical Trials
PremiumCompany Announcements
Luye Pharma’s Breakthrough Drug Enters Clinical Trials
6M ago
Luye Pharma’s ERZOFRI Wins FDA Approval
PremiumCompany Announcements
Luye Pharma’s ERZOFRI Wins FDA Approval
6M ago
Luye Pharma Group Announces Major Investment Deal
PremiumCompany Announcements
Luye Pharma Group Announces Major Investment Deal
6M ago
Luye Pharma’s New Pain Drug Approved in China
PremiumCompany Announcements
Luye Pharma’s New Pain Drug Approved in China
7M ago
Luye Pharma’s LY03010 Clears FDA Inspection
PremiumCompany AnnouncementsLuye Pharma’s LY03010 Clears FDA Inspection
7M ago
Luye Pharma’s New Parkinson’s Drug Approved in China
Premium
Company Announcements
Luye Pharma’s New Parkinson’s Drug Approved in China
8M ago
Luye Pharma’s New Schizophrenia Treatment Approved
Premium
Company Announcements
Luye Pharma’s New Schizophrenia Treatment Approved
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >